Van Lanschot Kempen Investment Management’s CME Group CME Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,239	Closed	-$7.98M	–	245
2025 Q4	$7.98M	Sell	29,239 -1,491	-5%	-$405K	0.07%	174
2025 Q3	$8.3M	Buy	30,730 +710	+2%	+$193K	0.07%	174
2025 Q2	$8.27M	Sell	30,020 -68,284	-69%	-$18.6M	0.08%	169
2025 Q1	$26.1M	Buy	98,304 +91	+0.1%	+$22.4K	0.27%	80
2024 Q4	$22.8M	Sell	98,213 -21,108	-18%	-$4.85M	0.23%	101
2024 Q3	$26.3M	Sell	119,321 -28,696	-19%	-$5.94M	0.27%	96
2024 Q2	$29.1M	Buy	148,017 +24,682	+20%	+$5.1M	0.33%	78
2024 Q1	$26.6M	Buy	123,335 +6,614	+6%	+$1.39M	0.33%	82
2023 Q4	$24.6M	Sell	116,721 -7,367	-6%	-$1.57M	0.34%	84
2023 Q3	$24.8M	Buy	124,088 +1,449	+1%	+$288K	0.46%	72
2023 Q2	$22.7M	Buy	122,639 +3,114	+3%	+$575K	0.41%	82
2023 Q1	$22.9M	Buy	119,525 +25,791	+28%	+$4.66M	0.44%	79
2022 Q4	$15.8M	Buy	+93,734	New	+$16.3M	0.46%	77
2020 Q2	–	Sell	-6,940	Closed	-$1.2M	–	169
2020 Q1	$1.2M	Buy	6,940 +125	+2%	+$24.9K	0.1%	116
2019 Q4	$1.37M	Buy	+6,815	New	+$1.4M	0.09%	122
2019 Q2	–	Sell	-228	Closed	-$38K	–	188
2019 Q1	$38K	Buy	+228	New	+$40.3K	﹤0.01%	179

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Van Lanschot Kempen Investment Management's CME Position: Q1 2026 in Review

Van Lanschot Kempen Investment Management sold out of CME Group (CME) in Q1 2026, closing a stake of 29,239 shares — an estimated $7.98M sold.

Van Lanschot Kempen Investment Management first reported a position in CME in Q1 2019 and held it in 16 quarters. The position peaked at $29.1M in Q2 2024. 1,799 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Van Lanschot Kempen Investment Management reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
Van Lanschot Kempen Investment Management sold 29,239 CME Group shares in Q1 2026, an estimated $7.98M.
Van Lanschot Kempen Investment Management first reported a position in CME Group in Q1 2019 and held it in 16 quarters.
Van Lanschot Kempen Investment Management's CME Group position peaked at $29.1M in Q2 2024.
1,799 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.